COLPANI, Agnese
 Distribuzione geografica
Continente #
NA - Nord America 2.099
AS - Asia 915
EU - Europa 571
SA - Sud America 525
Continente sconosciuto - Info sul continente non disponibili 58
AF - Africa 43
Totale 4.211
Nazione #
US - Stati Uniti d'America 2.040
BR - Brasile 460
SG - Singapore 412
CN - Cina 152
IT - Italia 144
DE - Germania 136
VN - Vietnam 106
FI - Finlandia 99
HK - Hong Kong 82
FR - Francia 48
AR - Argentina 30
CA - Canada 30
GB - Regno Unito 30
RU - Federazione Russa 22
BD - Bangladesh 20
IN - India 18
TR - Turchia 16
ES - Italia 14
IQ - Iraq 14
MX - Messico 13
PK - Pakistan 13
JP - Giappone 12
MA - Marocco 12
VE - Venezuela 12
PL - Polonia 10
UZ - Uzbekistan 9
AT - Austria 8
CZ - Repubblica Ceca 8
EC - Ecuador 8
AE - Emirati Arabi Uniti 7
ID - Indonesia 7
NL - Olanda 7
UA - Ucraina 7
ZA - Sudafrica 7
AZ - Azerbaigian 6
BE - Belgio 6
CO - Colombia 6
JM - Giamaica 6
KR - Corea 6
SE - Svezia 6
KE - Kenya 5
LT - Lituania 5
EG - Egitto 4
JO - Giordania 4
KG - Kirghizistan 4
LB - Libano 4
SA - Arabia Saudita 4
BG - Bulgaria 3
IL - Israele 3
NP - Nepal 3
PS - Palestinian Territory 3
RS - Serbia 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
CL - Cile 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
IE - Irlanda 2
KZ - Kazakistan 2
MK - Macedonia 2
MT - Malta 2
MY - Malesia 2
MZ - Mozambico 2
PA - Panama 2
PE - Perù 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
NI - Nicaragua 1
OM - Oman 1
PY - Paraguay 1
SR - Suriname 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 4.154
Città #
Dallas 991
Singapore 220
San Jose 168
Ashburn 119
Munich 102
Hong Kong 81
Helsinki 77
Council Bluffs 66
New York 63
Beijing 55
Los Angeles 49
Columbus 44
São Paulo 40
Lauterbourg 33
Ho Chi Minh City 32
Chandler 23
Hanoi 23
Atlanta 20
Santa Clara 19
Shanghai 19
Palermo 17
Rio de Janeiro 16
Montreal 13
Denver 12
Frankfurt am Main 11
Milan 11
Tokyo 11
Belo Horizonte 10
Rome 10
Chicago 9
Turku 9
Brno 8
Chennai 8
Florence 8
Lahore 8
Nuremberg 8
Orem 8
Porto Alegre 8
San Francisco 8
Baghdad 7
Brasília 7
Brooklyn 7
Buffalo 7
Haiphong 7
São José dos Campos 7
Warsaw 7
Campinas 6
Falkenstein 6
Guarulhos 6
Houston 6
Lappeenranta 6
Seoul 6
Tashkent 6
Toronto 6
Ankara 5
Antonimina 5
Baku 5
Boston 5
Brussels 5
Cagliari 5
Düsseldorf 5
Fortaleza 5
London 5
Nairobi 5
Santo André 5
Sassari 5
Stockholm 5
Amman 4
Bishkek 4
Contagem 4
Curitiba 4
Da Nang 4
Dhaka 4
Florianópolis 4
Guayaquil 4
Jyväskylä 4
Kingston 4
Madrid 4
New Delhi 4
Phoenix 4
Recife 4
Vienna 4
Biên Hòa 3
Boardman 3
Bogotá 3
Bragança Paulista 3
Buenos Aires 3
Campos dos Goytacazes 3
Caruaru 3
Casablanca 3
City of London 3
Duque de Caxias 3
Hortolândia 3
Imbituba 3
Ipatinga 3
Johannesburg 3
Manaus 3
Manchester 3
Maracaibo 3
Mexico City 3
Totale 2.713
Nome #
Tuberculosis-Induced Immune-Mediated Necrotizing Myopathy: A Challenging Case Scenario in a Non-Endemic Country 575
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 268
New treatment strategies for HIV-positive cancer patients undergoing anticancer medical treatment: update of the literature 248
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 156
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 143
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 135
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 135
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 132
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 131
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? 122
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience 121
Vaccination and Antiviral Treatment Reduce the Time to Negative SARS-CoV-2 Swab: A Real-Life Study 119
Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations 112
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression 110
What do We Know about Cryptic Aspergillosis? 109
Living with HIV and Getting Vaccinated: A Narrative Review 107
Quick diagnostic approach for HIV/STDs among migrants: results from a monocentric Italian cohort 106
The current and future off-label uses of dalbavancin: a narrative review 101
Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned? 100
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort 97
New score to predict COVID-19 progression in vaccine and early treatment era: the COVID-19 Sardinian Progression Score (CSPS) 96
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort 89
Sexually Transmitted Infections Prevalence and Cascade of Care among Undocumented Sex Workers: A Twenty-Year-Long Experience 87
Perspectives on climate action and the changing burden of infectious diseases among young Italian doctors and students: a national survey 81
What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study 80
Comparing large language models for antibiotic prescribing in different clinical scenarios: author's response 67
Incidence and burden of long COVID in Africa: a systematic review and meta-analysis 66
Viral Hepatitis C New Microelimination Pathways Objective: Psychiatric Communities HCV Free 65
Special Issue "Efficacy and Safety of Antiviral Therapy" 61
Shedding new light on COVID-19 therapeutics during the omicron era: a deeper dive into real-world data 57
The high burden of pediatric cystic echinococcosis in Kazakhstan: epidemiological and clinical consequences 51
Comparing large language models for antibiotic prescribing in different clinical scenarios: which performs better? 44
Present and future of HIV pre-exposure prophylaxis: a narrative review 36
Bictegravir/emtricitabine/tenofovir alafenamide in people with HIV aged ≥50: low discontinuation rates and favorable metabolic outcomes over 36 months 36
Is ChatGPT-4 accurate and complete when answering questions on tuberculosis? Results of the ChatGTB study 30
Phage to ESKAPE: Personalizing Therapy for MDR Infections—A Comprehensive Clinical Review 27
Long-acting CAB + RPV: safety, efficacy, and discontinuation risks in ODOACRE cohort 24
Exploring the impact of Cabotegravir‐Rilpivirine long‐acting on weight gain, body composition and quality of life in adults living with HIV 23
Risk of autochthonous human schistosomiasis transmission in Italy 19
Ultrasound-based population survey for abdominal cystic echinococcosis in Albania: Results from the NDTND project 19
Use of Tobacco and Alternative Nicotine Products Among People with HIV: A Cross-Sectional Multicenter Survey 18
Reproducibility of AI-generated antibiotic recommendations in standardised clinical scenarios: A proof-of-concept experimental study 8
Totale 4.211
Categoria #
all - tutte 15.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.258


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202368 0 7 2 6 4 15 3 4 3 9 9 6
2023/2024167 11 8 10 6 52 31 3 5 1 2 14 24
2024/20251.200 26 6 62 37 28 64 141 234 377 150 52 23
2025/20262.422 94 397 734 254 241 100 261 61 83 123 35 39
2026/2027354 209 145 0 0 0 0 0 0 0 0 0 0
Totale 4.211